Compass Therapeutics, Inc.
CMPX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001738021
In the last 90 days, Compass Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $363.4M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Compass Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- 0 vs. Q1 2022
- Shares held
- 61.9M
- −482.7K (−0.8%) vs. Q1 2022
- Total value
- $163.9M
- +$78.6M (+92.1%) vs. Q1 2022
- New holders
- 6
- 6 more added
- Sold out
- 6
- 8 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMPX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 215 | $363.4M |
| Q1 2026 | 201 | $921.3M |
| Q4 2025 | 173 | $881.5M |
| Q3 2025 | 125 | $528.7M |
| Q2 2025 | 103 | $281.5M |
| Q1 2025 | 108 | $206.1M |
| Q4 2024 | 92 | $147.0M |
| Q3 2024 | 79 | $169.6M |
| Q2 2024 | 82 | $93.4M |
| Q1 2024 | 78 | $187.2M |
| Q4 2023 | 77 | $134.3M |
| Q3 2023 | 76 | $176.7M |
| Q2 2023 | 73 | $287.7M |
| Q1 2023 | 73 | $266.5M |
| Q4 2022 | 55 | $401.4M |
| Q3 2022 | 38 | $145.6M |
| Q2 2022 | 34 | $163.9M |
| Q1 2022 | 34 | $85.4M |
| Q4 2021 | 37 | $201.6M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Compass Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 100 | $0 | 0.00% | +100 | New |
| Royal Bank of Canada | 228 | $1.00K | 0.00% | −555−70.9% | Reduced |
| Morgan Stanley | 613 | $2.00K | 0.00% | −26,364−97.7% | Reduced |
| Charter Oak Capital Management, LLC | 1,483 | $4.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,370 | $4.00K | 0.00% | +1,370 | New |
| UBS Group AG | 7,228 | $19.0K | 0.00% | 00.0% | Unchanged |
| Flagship Harbor Advisors, LLC | 14,000 | $37.0K | 0.00% | +14,000 | New |
| B. Riley Wealth Management, Inc. | 14,918 | $40.0K | 0.00% | 00.0% | Unchanged |
| Mascoma Wealth Management LLC | 15,682 | $42.0K | 0.01% | 00.0% | Unchanged |
| Marshall Wace, LLP | 23,727 | $63.0K | 0.00% | +23,727 | New |
| Geode Capital Management, LLC | 24,857 | $65.0K | 0.00% | 00.0% | Unchanged |
| New Capital Management LP | 24,243 | $69.0K | 0.04% | +24,243 | New |
| Millennium Management LLC | 27,861 | $74.0K | 0.00% | −10,684−27.7% | Reduced |
| CM Management, LLC | 30,000 | $80.0K | 0.09% | −270,000−90.0% | Reduced |
| Salem Investment Counselors Inc | 30,000 | $80.0K | 0.00% | −70,000−70.0% | Reduced |
| Renaissance Technologies LLC | 66,165 | $175.0K | 0.00% | +52,865+397.5% | Added |
| LMR Partners LLP | 100,000 | $265.0K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 163,426 | $433.0K | 0.00% | +163,426 | New |
| DAFNA Capital Management LLC | 198,094 | $525.0K | 0.14% | +2,003+1.0% | Added |
| Fred Alger Management, LLC | 608,536 | $1.61M | 0.01% | 00.0% | Unchanged |
| Monashee Investment Management LLC | 1,230,441 | $3.26M | 1.19% | −39,770−3.1% | Reduced |
| Vanguard Group Inc | 1,501,973 | $3.98M | 0.00% | −70,909−4.5% | Reduced |
| Blackstone Group Inc. | 1,505,738 | $3.99M | 0.01% | 00.0% | Unchanged |
| Foresite Capital Opportunity Management V, LLC | 1,554,250 | $4.12M | 10.38% | +454,250+41.3% | Added |
| Consonance Capital Management LP | 1,603,789 | $4.22M | 17.79% | −1,896,211−54.2% | Reduced |
| Vivo Capital, LLC | 2,000,000 | $5.30M | 0.53% | 00.0% | Unchanged |
| Avidity Partners Management LP | 2,000,000 | $5.30M | 0.12% | 00.0% | Unchanged |
| CHI Advisors LLC | 2,829,712 | $7.50M | 2.87% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 3,347,171 | $8.80M | 0.01% | +153,877+4.8% | Added |
| Foresite Capital Management V, LLC | 4,400,000 | $11.7M | 8.15% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 4,406,600 | $11.7M | 0.03% | +2,129,600+93.5% | Added |
| Rock Springs Capital Management LP | 5,328,088 | $14.1M | 0.41% | 00.0% | Unchanged |
| FMR LLC | 6,872,414 | $18.2M | 0.00% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 21,960,850 | $58.2M | 1.13% | +317,875+1.5% | Added |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −582,750−100.0% | Sold out |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −532,958−100.0% | Sold out |
| Alphabet Inc. | 0 | $0 | 0.00% | −192,794−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −74,171−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −52,842−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −6−100.0% | Sold out |